Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.41 EUR | -41.01% | -.--% | -14.58% |
2023 | Traumhaus AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2023 | Traumhaus AG Provides Sales Guidance for the Year 2023 | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 69% by 2025.
- The company shows low valuation levels, with an enterprise value at 0.42 times its sales.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- For the past twelve months, EPS forecast has been revised upwards.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- TRU Stock
- Ratings Traumhaus AG